Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials

BACKGROUND: We conducted double-blind, placebo-controlled trials assessing the efficacy and tolerability of favipiravir in acute influenza. METHODS: Otherwise healthy adults with influenza-like symptoms and fever of ≤48 hours were randomized to favipiravir (1800 mg twice daily [BID] on day 1, 800 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayden, Frederick G, Lenk, Robert P, Stonis, Lucille, Oldham-Creamer, Catherine, Kang, Lih Lisa, Epstein, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650493/
https://www.ncbi.nlm.nih.gov/pubmed/35639525
http://dx.doi.org/10.1093/infdis/jiac135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650493/
https://www.ncbi.nlm.nih.gov/pubmed/35639525
http://dx.doi.org/10.1093/infdis/jiac135

Ejemplares similares